Variables | Number | Percents | |
---|---|---|---|
Opportunistic illness before initiation of ART | Had above one opportunistic infections | 201 | 27.5 % |
Had one opportunistic infection | 280 | 38.4 % | |
No opportunistic Infection | 249 | 34.1 % | |
Opportunistic illness after initiation of ART | Had above one opportunistic infections | 26 | 3.5 |
Had one opportunistic infection | 170 | 23.3 | |
No opportunistic infection | 534 | 73.2 | |
CPT prophylaxis | Present | 461 | 63.2 % |
Absent | 269 | 36.8 % | |
Functional status | Working | 495 | 68 % |
Bedridden | 39 | 5.4 % | |
Ambulatory | 194 | 26.6 % | |
Unknown | 2 | 0.003 % | |
WHO clinical stage | Stage I | 101 | 14.0 % |
Stage II | 148 | 20.4 % | |
Stage III | 413 | 57.0 % | |
Stage IV | 62 | 8.6 % | |
Unknown | 2 | 0.003 % | |
Hemoglobin (g/dl) | <10 | 110 | 15.1 % |
≥10 | 620 | 84.9 % | |
CD4 counts at baseline | ≤50 cells/mm3 | 106 | 14.5 % |
51 - 200 cells/mm3 | 398 | 54.5 % | |
201 - 350 cell/mm3 | 195 | 26.7 % | |
>350 cell/mm3 | 31 | 4.2 % | |
Weight at baseline | ≤45 | 160 | 21.9 % |
46 – 55 | 329 | 45.1 % | |
56 – 65 | 184 | 25.2 % | |
>65 | 57 | 7.8 % | |
Regimen at baseline | 1a = d4t-3TC-NVP | 268 | 37.0 % |
1b = d4t-3TC-EFV | 67 | 9.3 % | |
1c = AZT-3TC-NVP | 197 | 27.2 % | |
1d = AZT-3TC-EFV | 51 | 7.0 % | |
TDF-3TC_NVP | 141 | 19.5 % | |
Unknown | 6 | 0.008 % | |
Regimen adherence | Good | 675 | 92.5 |
Fair | 18 | 2.4 | |
Poor | 37 | 5.1 | |
Treatment outcome | On treatment | 423 | 57.9 % |
Dead | 92 | 12.6 % | |
Stopped | 4 | .5 % | |
Lost | 17 | 2.3 % | |
Transfer out | 109 | 14.9 % | |
Drop | 85 | 11.6 % |